Linden Thomas Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Linden Thomas Advisory Services's GILD Position: Q2 2026 in Review
Linden Thomas Advisory Services increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $80K and bringing the position to 27,150 shares worth $3.43M. The position accounts for 0.28% of the portfolio, ranked #93.
Linden Thomas Advisory Services first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.08M in Q4 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Linden Thomas Advisory Services held 27,150 shares of Gilead Sciences worth $3.43M as of Q2 2026.
- Linden Thomas Advisory Services bought 607 Gilead Sciences shares in Q2 2026, an estimated $80K.
- Gilead Sciences made up 0.28% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #93 holding.
- Linden Thomas Advisory Services first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
- Linden Thomas Advisory Services's Gilead Sciences position peaked at $6.08M in Q4 2025.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.